Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPGUERRA, E. N. S.SANTOS-SILVA, A. R.NORMANDO, A. G. C.SCARINI, J. F.SANTOS, J. A. DosBRANDãO, T. B.2023-12-042023-12-042023Guerra, E. N. S.; Santos-Silva, A. R.; Normando, A. G. C.; Scarini, J. F.; Dos Santos, J. A.; Brandão, T. B.. Management of Oral Lesions in COVID-19 Patients. In: . Clinical Decision-Making in Oral Medicine: A Concise Guide to Diagnosis and Treatment: SPRINGER INTERNATIONAL PUBLISHING, 2023. p.207-211.978-303114945-0; 978-303114944-3https://observatorio.fm.usp.br/handle/OPI/57253In COVID-19 patients, the infection can lead to taste disturbances, xerostomia, halitosis, parotitis, and oral mucosal lesions. Usually, the lesions are symptomatic and have no sex predilection. Patients with older age and greater severity of the disease present more disseminated and severe lesions. This chapter sought to describe the clinical presentation and specificities of managing orofacial lesions in patients with COVID-19, based on the best evidence of clinical effectiveness. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023.engrestrictedAccessCOVID-19Dry mouthHalitosisOrofacial manifestationsParotitisSARS-Cov-2XerostomiaManagement of Oral Lesions in COVID-19 PatientsbookPartCopyright SPRINGER INTERNATIONAL PUBLISHING10.1007/978-3-031-14945-0_28